Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Cancer Immunol Immunother
; 72(9): 3029-3043, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37310433
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD8-Positive T-Lymphocytes
/
4-1BB Ligand
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Alemania